SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.33-8.6%Jan 16 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (10248)5/28/1999 9:05:00 PM
From: aknahow  Read Replies (1) of 17367
 
Lend me your ears.

In June we have another presentation.

A New Therapy for Otitis Media with Effusion?"

Anyone think the presentation will say BPI is not worth considering as this new therapy?

J.J. Grote, Leiden University Medical Center (LUMC), Leiden, The
Netherlands, "Endotoxin, and its Relation with Otitis Media with Effusion"

M.J. Nell, Leiden University Medical Center (LUMC), Leiden, The
Netherlands, "Inhibition of Endotoxin Induced Morphological Changes in the Middle
Ear by BPI. A New Therapy for Otitis Media with Effusion?"

So we have good news we can count on. Involves children and a big market. True XOMA is far away from trials but the news could help focus attention on the potential for BPI.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News